The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. CRISPR Therapeutics AG’s current trading price is -51.48% away from its 52-week high, while its distance from the 52-week low is 21.03%. The stock’s price range for this period has been between $36.52 and $91.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 5.37 million for the day, a number notably higher than the average daily volume of 1.81 million over the last three months.
In terms of market performance, CRISPR Therapeutics AG had a fairly uneven. The highest value for the stock in the past year was $91.10 on 02/22/24, and the lowest value was recorded at $36.52 on 01/13/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
CRISPR Therapeutics AG (CRSP) has experienced a quarterly decline of -9.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.77B and boasts a workforce of 407 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.32, with a change in price of -4.04. Similarly, CRISPR Therapeutics AG recorded 1,533,615 in trading volume during the last 100 days, posting a change of -8.37%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRSP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRSP Stock Stochastic Average
As of today, CRISPR Therapeutics AG’s raw stochastic average for the last 50 days stands at 34.06%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 83.03%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 64.89% and 54.78%, respectively.
CRSP Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 12.30% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -21.41%. Over the past 30 days, the price of CRSP has fallen by 7.65%. And in the last five days, it has surged by 15.22%.
